Nirav Shah to Neoplasms
This is a "connection" page, showing publications Nirav Shah has written about Neoplasms.
Connection Strength
0.398
-
The role of noncovalent BTK inhibitors in the era of covalent BTK inhibitors. Clin Adv Hematol Oncol. 2024 Apr; 22(3):140-147.
Score: 0.301
-
Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer Therapy. Clin Pharmacol Ther. 2025 Jan; 117(1):34-55.
Score: 0.078
-
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood Adv. 2024 05 28; 8(10):2327-2331.
Score: 0.019